elecell lnc. continued its efforts to enter the global market by participating in the 'BIO USA 2026,' the world's largest bio-pharmaceutical industry exhibition held in San Diego, USA, for four days from June 22 to 25. Hosted annually by the Biotechnology Industry Association of the United States, 'BIO USA' is the world's most prestigious business platform, bringing together over 20,000 bio-specialized entrepreneurs, investors, and researchers from more than 70 countries to share innovative technologies and discuss business partnerships.

At this event, elecell unveiled its core pipeline, the 'Adhesive Bandage,' which recently completed US FDA Class 1 registration. Developed to promote human tissue regeneration and wound healing, this patch is a next-generation innovative medical device that integrates Electel’s proprietary electrical stimulation platform technology and bio-convergence technology.

elecell conducted intensive partnering meetings with promising global investors, distribution partners, and industry leaders through its Korea Pavilion booth and on-site partnering sessions. Through these meetings, the company discussed multifaceted cooperation strategies for technology licensing, joint R&D, and securing global local distribution networks, including those in North America, thereby laying a strong foundation for business expansion.

An official from elecell (CEO Hyung-seop Han) stated, “At BIO USA, the world’s largest bio stage, we were able to showcase elecell's proprietary electrical stimulation therapy technology and FDA Class 1 registered products for the first time and directly confirm the intense interest and demand from the global market,” adding, “Based on the valuable global networks and partnerships established at this event, we will accelerate our entry into the U.S. and global markets and do our best to ensure that this leads to tangible business results in the near future.”

Link to original articlehttps://www.kukinews.com/article/view/kuk202606240021